Adaptive Biotechnologies Corporation Common Stock (ADPT) is a publicly traded Healthcare sector company. As of July 18, 2026, ADPT trades at $22.84 with a market cap of $3.54B and a P/E ratio of -69.28. ADPT moved +3.71% today. Year to date, ADPT is +41.13%; over the trailing twelve months it is +118.29%. Its 52-week range spans $4.76 to $23.15. Analyst consensus is strong buy with an average price target of $20.67. Rallies surfaces ADPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ADPT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $22.84 |
| Market Cap | $3.54B |
| P/E Ratio | -69.28 |
| EPS | $-0.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.15 |
| 52-Week Low | $4.76 |
| Volume | 2.75M |
| Avg Volume | 0 |
| Revenue (TTM) | $295.41M |
| Net Income | $-49.64M |
| Gross Margin | 75.26% |
8 analysts cover ADPT: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.67.